FR
EN- A-
- A+
Partnership between the European Investment Bank (EIB) and Théa
The EIB will support the Research and Development of Théa by according 50 million euros to the company.
Under the European Fund for Strategic Investments which aims to support the innovation in Europe, the EIB will finance 50 million euros of Théa’s R&D.
This amount will give the opportunity to this company to develop new molecules…
The aim of Théa’s research program is to conceive new products to cure pathologies like glaucoma, dry eye, eye infections and to answer to patients’ needs.
The aim of this agreement is also to increase the number of positions in the field of R&D at Théa.
